PURPOSE: Cannabinoid CB1 receptors are found in abundance in the vertebrate eye, with most tissue types expressing this receptor. However, the function of CB1 receptors in corneal epithelial cells (CECs) is poorly understood. Interestingly, the corneas of CB1 knockout mice heal more slowly after injury via a mechanism proposed to involve protein kinase B (Akt) activation, chemokinesis, and cell proliferation. The current study examined the role of cannabinoids in CEC migration in greater detail. METHODS: We determined the role of CB1 receptors in corneal healing. We examined the consequences of their activation on migration and proliferation in bovine CECs (bCECs). We additionally examined the mRNA profile of cannabinoid-related genes and CB1 protein expression as well as CB1 signaling in bovine CECs. RESULTS: We now report that activation of CB1 with physiologically relevant concentrations of the synthetic agonist WIN55212-2 (WIN) induces bCEC migration via chemotaxis, an effect fully blocked by the CB1 receptor antagonist SR141716. The endogenous agonist 2-arachidonoylglycerol (2-AG) also enhances migration. Separately, mRNA for most cannabinoid-related proteins are present in bovine corneal epithelium and cultured bCECs. Notably absent are CB2 receptors and the 2-AG synthesizing enzyme diglycerol lipase-α (DAGLα). The signaling profile of CB1 activation is complex, with inactivation of mitogen-activated protein kinase (MAPK). Lastly, CB1 activation does not induce bCEC proliferation, but may instead antagonize EGF-induced proliferation. CONCLUSIONS: In summary, we find that CB1-based signaling machinery is present in bovine cornea and that activation of this system induces chemotaxis.
PURPOSE:CannabinoidCB1 receptors are found in abundance in the vertebrate eye, with most tissue types expressing this receptor. However, the function of CB1 receptors in corneal epithelial cells (CECs) is poorly understood. Interestingly, the corneas of CB1 knockout mice heal more slowly after injury via a mechanism proposed to involve protein kinase B (Akt) activation, chemokinesis, and cell proliferation. The current study examined the role of cannabinoids in CEC migration in greater detail. METHODS: We determined the role of CB1 receptors in corneal healing. We examined the consequences of their activation on migration and proliferation in bovine CECs (bCECs). We additionally examined the mRNA profile of cannabinoid-related genes and CB1 protein expression as well as CB1 signaling in bovine CECs. RESULTS: We now report that activation of CB1 with physiologically relevant concentrations of the synthetic agonist WIN55212-2 (WIN) induces bCEC migration via chemotaxis, an effect fully blocked by the CB1 receptor antagonist SR141716. The endogenous agonist 2-arachidonoylglycerol (2-AG) also enhances migration. Separately, mRNA for most cannabinoid-related proteins are present in bovine corneal epithelium and cultured bCECs. Notably absent are CB2 receptors and the 2-AG synthesizing enzyme diglycerol lipase-α (DAGLα). The signaling profile of CB1 activation is complex, with inactivation of mitogen-activated protein kinase (MAPK). Lastly, CB1 activation does not induce bCEC proliferation, but may instead antagonize EGF-induced proliferation. CONCLUSIONS: In summary, we find that CB1-based signaling machinery is present in bovinecornea and that activation of this system induces chemotaxis.
Authors: Brian D Hudson; Meggie Beazley; Anna-Maria Szczesniak; Alex Straiker; Melanie E M Kelly Journal: J Pharmacol Exp Ther Date: 2011-09-01 Impact factor: 4.030
Authors: Daniel K Nomura; Donald P Lombardi; Jae Won Chang; Sherry Niessen; Anna M Ward; Jonathan Z Long; Heather H Hoover; Benjamin F Cravatt Journal: Chem Biol Date: 2011-07-29
Authors: Allyn C Howlett; Christopher S Breivogel; Steven R Childers; Samuel A Deadwyler; Robert E Hampson; Linda J Porrino Journal: Neuropharmacology Date: 2004 Impact factor: 5.250
Authors: Jason L Niehaus; Yunguang Liu; Kathleen T Wallis; Michaela Egertová; Sheela G Bhartur; Somnath Mukhopadhyay; Shanping Shi; Hengjun He; Dana E Selley; Allyn C Howlett; Maurice R Elphick; Deborah L Lewis Journal: Mol Pharmacol Date: 2007-09-25 Impact factor: 4.436
Authors: Sally Miller; Laura Daily; Vijai Dharla; Juerg Gertsch; Michael S Malamas; Iwao Ojima; Martin Kaczocha; Daisuke Ogasawara; Alex Straiker Journal: Exp Eye Res Date: 2020-09-23 Impact factor: 3.467
Authors: Dinesh Thapa; Elizabeth A Cairns; Anna-Maria Szczesniak; Pushkar M Kulkarni; Alex J Straiker; Ganesh A Thakur; Melanie E M Kelly Journal: Molecules Date: 2020-01-20 Impact factor: 4.411
Authors: Amanda Thayer; Natalia Murataeva; Vanessa Delcroix; Jim Wager-Miller; Helen P Makarenkova; Alex Straiker Journal: Invest Ophthalmol Vis Sci Date: 2020-08-03 Impact factor: 4.799